Trade CELC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Celcuity Inc. (CELC) is trading at US$88.44, down 5.15% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$4.58B. Over the past 52 weeks, CELC has traded between US$44.42 and US$151.02. On Syfe you can trade CELC with $0 commission and add it to your watchlist.
| Previous close | US$93.24 |
|---|---|
| Market cap | US$4.58B |
| 52-week range | US$44.42 – US$151.02 |
| Volume | 676.56K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Celcuity Inc.
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Year: 2017
Celcuity's REVTORPYK Gets FDA Approval for HR+/HER2- Breast Cancer
Jul 14, 9:19 PM · MT Newswires
Celcuity Prices $500 Million Convertible Notes Due 2032
Jun 4, 12:12 PM · MT Newswires
Celcuity Inc. (CELC) stock is trading at US$88.44, -5.15% from the previous close of US$93.24.
The market cap for Celcuity Inc. (CELC) stock is approximately US$4.58B.
The 52-week high for Celcuity Inc. (CELC) stock is US$151.02.
The 52-week low for Celcuity Inc. (CELC) stock is US$44.42.
Celcuity Inc. (CELC) does not currently pay a dividend.
Stay on top of CELC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
